ChartRow logo
Share this page
KRYS
$316.58-4.07%
as of close, Oct 16, 2026
☾ AH $316.58 -4.07%
PeersMRNALLYMDTUNHJNJTMO

KRYS — Krystal Biotech Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
What would $1,000 invested in KRYS be worth today? →
KRYS returns: By year · By month · By week · Trailing

Key stats#

Price data

Price
$316.58
YTD price return
+28.41%
YTD total return
+28.41%
Next earnings
Nov 2, 2026
Market cap
9.4B
Enterprise value
8.5B
Shares outstanding
29.6M
52W low
$183.03
52W high
$382.54
From 52W high
-17.24%
From 52W low
+72.97%
52W range
67%

Volume

Rel volume
0.79×
30D volume
285.1K
30D $ vol
95.7M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
−$26.2M
Insider net 1Y
−$83.3M

Form 4 transactions by trade date, as filed; latest on file 2026-09-04.

Fundamentals

Sales (ttm)
440.5M
Sales/share
$14.88
EPS (ttm)
$7.96
FCF (ttm)
257.8M
FCF/share
$8.71
Book value/share
$45.92
Net margin
54.82%
ROE
17.77%
ROA
16.09%
Current ratio
8.32

Growth (CAGR, ttm) · 10Y

Sales
+22.64%n/an/an/a
Net income
+64.63%n/an/an/a
FCF
+39.04%n/an/an/a
Shares
+2.27%+4.32%+5.92%n/a

Per-share growth (CAGR, ttm) · 10Y

EPS
+62.13%n/an/an/a
Sales/share
+19.93%n/an/an/a
FCF/share
+35.96%n/an/an/a
Book value/share
+27.73%+31.25%+19.50%+94.54%
Price
+68.16%+40.55%+45.37%n/a
Total return
+68.16%+40.55%+45.37%n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
39.8×
Fwd P/E
34.6×
P/S (ttm)
21.3×
P/B (mrq)
6.9×
P/FCF (ttm)
36.4×
EV/EBITDA (fy)
41.9×
EV/Sales (ttm)
19.4×
FCF yield (ttm)
2.75%
Buyback yield (realized, 1y)
-2.27%
Shareholder yield (realized, 1y)
-2.27%
Buyback yield (cash, ttm)
0.00%
Shareholder yield (cash, ttm)
0.00%

Vs own 10Y history

P/B
94th

Bar = where today’s multiple sits in KRYS’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

1D
-4.07%
5D
-4.53%
1M
-5.97%
3M
-7.38%
YTD
+28.41%
1Y
+68.10%
5Y
+549.79%

Recent filings#

All filings and insider trades →

Financial statements

Open full KRYS financials →
Loading financial statements…
TickerName1M1D
LLYEli Lilly and Company+10.48%+0.43%
JNJJohnson & Johnson-4.38%+0.90%
ABBVAbbVie Inc.+8.73%+0.71%
UNHUnitedHealth Group Incorporated Common Stock (DE)+6.97%-1.29%
MRKMerck & Co. Inc.+0.72%+0.52%
NVSNovartis AG+8.59%+0.16%
TMOThermo Fisher Scientific Inc.+6.41%-0.93%
AMGNAmgen Inc.+14.92%-0.35%